Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-14-024414)

Filing Details

Accession Number:: 0001140361-14-024414
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-03 18:54:11
Reporting Period:: 2014-06-02

Filing Date:: 2014-06-03
Accepted Time:: 2014-06-03 18:54:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557533	Robert Jeffrey Ajer	C/O Biomarin Pharmaceutical Inc., 105 Digital Drive Novato CA 94949	Svp, Chief Commercial Of	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-06-02	377	$57.83	20,190	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Transaction made pursuant to a Rule 10b5-1 plan executed on December 12, 2013.
The price in Column 4 is a weighted average price. The prices actually received ranged from $57.50 to $58.22. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.